The US menopause market is massive and if affected women can be given another option then that is great. Let's hope of continued success for Donesta and that Mithra and Mayne Pharma can do another deal and build on the significant marketing and distribution capability already established for Nextstellis.
- Forums
- ASX - By Stock
- MYX
- Mithra’s Donesta phase 3 trial results
Mithra’s Donesta phase 3 trial results, page-3
Featured News
Add MYX (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.88 |
Change
0.000(0.00%) |
Mkt cap ! $330.0M |
Open | High | Low | Value | Volume |
$3.89 | $3.94 | $3.87 | $178.6K | 45.81K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 587 | $3.88 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.90 | 137 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 137 | 3.870 |
1 | 137 | 3.860 |
2 | 1337 | 3.850 |
1 | 137 | 3.840 |
3 | 1637 | 3.830 |
Price($) | Vol. | No. |
---|---|---|
3.900 | 137 | 1 |
3.910 | 137 | 1 |
3.920 | 137 | 1 |
3.930 | 137 | 1 |
3.940 | 1137 | 2 |
Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |